Ranbaxy gains nearly 1% as FDA approves Gurgaon & Romania R&D centres

Subscribe to GoodReturns

Ranbaxy gains nearly 1% as FDA approves Gurgaon & Romania R&D centres
Shares of Ranbaxy Laboratories Ltd. fell nearly 1 per cent in early trade on Bombay Stock Exchange (BSE) after reports suggested that US drug regulator inspected its two centres in Gurgaon & Romania R&D and cleared it.

The shares of company fell as much as 0.88 per cent to trade at Rs 471 a piece on the BSE. In a similar fashion, shares of the company fell 1.07 per cent to Rs 472.35 a piece on National Stock Exchange. Meanwhile, the broader benchmark Sensex was quoting at 22,717.06, up 14.72 points or 0.06 per cent at 10:27 hours.

Dion Global Solutions Ltd.

Read more about: ranbaxy laboratories, sensex, bse, fda
Story first published: Thursday, April 10, 2014, 12:46 [IST]
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?